DexCom Promotes Jake Leach to Chief Operating Officer
August 31 2022 - 5:00PM
Business Wire
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time
continuous glucose monitoring for people with diabetes, announced
today the promotion of Jake Leach to the role of chief operating
officer.
Leach has most recently served as chief technology officer at
Dexcom since 2018, leading the organization’s research, product
development, project management and engineering departments. An
18-year veteran of the company, Jake joined Dexcom in 2004 to lead
the development of sensor electronics for the first commercial
Dexcom CGM system. Since then, he has led the teams responsible for
developing multiple generations of Dexcom CGM, including Dexcom G6,
the best-selling real-time CGM in the world.
“For nearly two decades, Jake has helped lead technology
development at Dexcom, ensuring our organization is on the
forefront of innovation in continuous glucose monitoring and data
connectivity,” said Kevin Sayer, chairman, president and chief
executive officer at Dexcom. “In this new role, Jake will expand
upon his proven leadership and industry expertise to ensure that
Dexcom remains at the forefront of sensing technology and
well-positioned to bring Dexcom CGM to the millions of additional
people who stand to benefit from it.”
As chief operating officer, Leach will have end-to-end
responsibility for product at Dexcom, driving day-to-day
decision-making and resource allocation across all major
product-facing groups. In addition, Jake will oversee several
executive leadership functions, including global operations,
research and development, quality management and regulatory,
creating an integrated management structure that strengthens the
company’s ability to execute on its vision for long-term
sustainable growth.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of
diabetes through innovative continuous glucose monitoring (CGM)
systems. Headquartered in San Diego, California, and with
operations across Europe and select parts of Asia/Oceania, Dexcom
has emerged as a leader of diabetes care technology. By listening
to the needs of users, caregivers, and providers, Dexcom simplifies
and improves diabetes management around the world. For more
information about Dexcom CGM, visit www.dexcom.com.
© 2022 Dexcom, Inc. Dexcom and Dexcom G6 are registered
trademarks of DexCom, Inc. in the U.S., and may be registered in
other countries. All rights reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220831005236/en/
Media Contact James McIntosh
619-884-2118 james.mcintosh@dexcom.com
Investor Contact Sean
Christensen 858-203-6657 sean.christensen@dexcom.com
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jun 2024 to Jul 2024
DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Jul 2023 to Jul 2024